Increase in serum interleukin-6, plasma ACTH and serum cortisol levels after systemic interferon-alpha administration
- PMID: 8556063
- DOI: 10.1507/endocrj.42.551
Increase in serum interleukin-6, plasma ACTH and serum cortisol levels after systemic interferon-alpha administration
Abstract
Systemic administration of human interferon-alpha stimulates the pituitary-adrenal axis in men, but the exact mechanism still remains to be established. The present study was undertaken to examine the hypothesis that interferon-alpha may alter the circulating concentrations of the cytokines which involve the activation of the pituitary-adrenal axis. Eleven patients with chronically active hepatitis C were treated with human lymphoblastoid interferon-alpha (IFN: 6 x 10(6) IU/day) and changes in plasma adrenocorticotropin (ACTH), serum cortisol and cytokine concentrations were observed on both the first and second days of the treatment. Subcutaneous administration of IFN significantly increased plasma ACTH and serum cortisol concentrations by 3 h after the injection. Serum interleukin-6 (IL-6) increased with the increase in circulating ACTH and cortisol. There was a significant correlation between serum cortisol and IL-6 concentrations at 3 h. In contrast, an increase in serum interleukin-1 beta was only observed in one case. On the second day of IFN treatment, simultaneous administration of 25 mg diclofenac sodium eliminated the IFN effects on circulating ACTH, cortisol and IL-6 concentrations. The present studies demonstrated that circulating IL-6 increases after systemic IFN administration, resulting in activation of the pituitary-adrenal axis.
Similar articles
-
Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior.Mol Psychiatry. 2010 May;15(5):535-47. doi: 10.1038/mp.2008.58. Epub 2008 Jun 3. Mol Psychiatry. 2010. PMID: 18521089 Free PMC article. Clinical Trial.
-
Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.Am J Psychiatry. 2003 Jul;160(7):1342-5. doi: 10.1176/appi.ajp.160.7.1342. Am J Psychiatry. 2003. PMID: 12832253 Clinical Trial.
-
Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis.J Clin Endocrinol Metab. 1997 Apr;82(4):1279-83. doi: 10.1210/jcem.82.4.3852. J Clin Endocrinol Metab. 1997. PMID: 9100607
-
Altered adrenocorticotropin and cortisol response to corticotropin-releasing hormone in HIV-1 infection.Eur J Endocrinol. 1995 Aug;133(2):173-9. doi: 10.1530/eje.0.1330173. Eur J Endocrinol. 1995. PMID: 7655641
-
Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus.Physiol Behav. 2016 Nov 1;166:14-21. doi: 10.1016/j.physbeh.2015.12.013. Epub 2015 Dec 17. Physiol Behav. 2016. PMID: 26703235 Free PMC article.
Cited by
-
Potential role of type I interferons in the treatment of pituitary adenomas.Rev Endocr Metab Disord. 2009 Jun;10(2):125-33. doi: 10.1007/s11154-008-9083-3. Epub 2008 Jul 6. Rev Endocr Metab Disord. 2009. PMID: 18604644 Review.
-
Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder.J Psychiatry Neurosci. 2009 Jan;34(1):4-20. J Psychiatry Neurosci. 2009. PMID: 19125209 Free PMC article. Review.
-
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.Neuroscience. 2013 Aug 29;246:199-229. doi: 10.1016/j.neuroscience.2013.04.060. Epub 2013 May 3. Neuroscience. 2013. PMID: 23644052 Free PMC article. Review.
-
Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy.PLoS One. 2012;7(6):e38668. doi: 10.1371/journal.pone.0038668. Epub 2012 Jun 6. PLoS One. 2012. PMID: 22701688 Free PMC article. Clinical Trial.
-
Gene expression biomarkers of response to citalopram treatment in major depressive disorder.Transl Psychiatry. 2011 Jun 21;1(6):e13. doi: 10.1038/tp.2011.12. Transl Psychiatry. 2011. PMID: 22832429 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical